Medical exoskeletons are robotic structures that are worn externally by individuals to enhance or enable mobility. These robotic suits assist patients in regaining body functions or independence. Over the past decade, medical exoskeletons have emerged as an important field of research with the potential to revolutionize health and rehabilitation. Let's take a closer look at the development and applications of medical exoskeletons globally.
Early Developments and Research
The earliest attempts at medical exoskeleton development started in the 1960s with the goal of assisting paraplegics and other patients with mobility impairments. However, limitations in material science, power sources and control algorithms restricted progress. Significant advances occurred in the 1980s and 90s driven by research from institutions like the NASA and DARPA. New materials like lightweight carbon fiber and advances in batteries, sensors and computer technology enabled more capable prototypes to be built.
In the 2000s, medical exoskeleton research expanded globally with projects launched by universities, startups and large companies. Pneumatic and electric actuators improved strength and precision. Control systems for stance and gait were refined through extensive clinical trials. By 2010, several lower limb exoskeletons had received regulatory approval and begun limited commercial use, demonstrating the technical and practical feasibility of medical exoskeleton assisted mobility.
Current Applications and Devices
Lower limb exoskeletons Global Medical Exoskeleton have become the most developed application for medical exoskeletons. Examples include ReWalk by ReWalk Robotics which allows paraplegics to walk, stand and climb stairs. Ekso by Ekso Bionics is used widely in rehabilitation, allowing more natural gait patterns for stroke victims and spinal cord injuries. Rex by Rex Bionics is designed for cheap distributed production. Other areas seeing progress include upper limb exoskeletons to aid strokes victims and exoskeletons targeted at elderly assistance.
Lower back exoskeletons aim to reduce strain and risk of injury for laborers, nurses and construction workers who undertake manual lifting and carrying activities. Examples are University of Pittsburgh's RB3D and suitX's Phoenix, which help distribute load across the hips and legs. Researchers are also exploring wrist and hand exoskeletons to augment gripping, picking and delicate manipulation for applications such as advanced manufacturing.
At the medical frontier, exoskeletons are being examined for more radical applications such as paraplegic running and climbing. The next decade may see exoskeleton enhanced Paralympic athletes smashing records. Exoskeletons are also being used in post-operative gait rehabilitation and for reducing symptoms in stroke and Parkinson's disease patients. The emerging field of soft exoskeletons powered by innovative materials like shape memory alloys and pneumatics also holds promise.
Global Trends and Investments
The United States has been a leader in medical exoskeleton technology, propelled by initiatives from DARPA and NIH. It continues investing over $100 million annually. Projects range from the HAL exoskeleton suit to soft robotic prostheses. Japan also maintains a strong research effort with projects originating from universities like Keio and companies such as Cyberdyne.
Europe has emerged as another important region, with the EU funding numerous collaborative medical robotic programs under its research framework programs totaling over a billion euros since 2014. The United Kingdom, Germany, Netherlands and Italy have all made significant investments in medical exoskeleton technologies.
China and South Korea are actively catching up, pursuing both indigenous development and partnerships with global firms. China aims to be a leader by 2030 and launched the "China Medical Robot Clinical Application Research Project" with a budget of over half a billion dollars. Countries across Asia, South America and the Middle East are increasingly participating in medical exoskeleton research and deployment.
Private capital has also poured into startups in this space. Ekso Bionics raised $55 million in its IPO in 2014. Other startups developing promising technologies include Rewalk Robotics, Indego, SuitX, Cyberdyne and RxRobotics. Industry analysts forecast the medical exoskeleton market growing to over $1 billion by 2025 as regulatory approvals accelerate and insurance coverage expands for these life-changing systems.
Roadblocks and Future Outlook
While exciting progress has been made, hurdles remain before medical exoskeletons achieve widespread adoption and affordability. Cost is a major limitation today, with exoskeletons usually priced over $50,000 each. Bulk, weight and limited battery life also restrict mobility. Refining control interfaces to achieve safe, natural motion on varied terrains continues to challenge engineers.
For the next decade, priorities are miniaturization of components, integration of personalized sensing and machine learning, standardization of interfaces to enable modularity, and whole body medical exoskeleton solutions. Addressing regulatory hurdles and expanding evidence on health outcomes will be critical for reimbursement and market expansion. Success in these areas may see medical exoskeletons emerging from rehabilitation clinics into homes and workplaces, empowering millions globally with enhanced mobility. With continued progress, the exciting vision of versatile, soft robotic suits assisting all ages with equal capacity for movement may become a reality in the coming decades.
For more insights, read-https://www.pressreleasebulletin.com/global-medical-exoskeletons-trends-size-and-share-analysis/
Comments
0 comment